dr. M. Tamminga

Telephone:
E-mail:
m.tamminga umcg.nl
Research
1 - 26 out of 26Page size: 50
- 2020
- Tamminga, M., Oomens, L., Hiltermann, T. J. N., Andree, K. C., Tibbe, A., Broekmaat, J., Schuuring, E., Terstappen, L. W. M. M., & Groen, H. J. M. (2020). Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients. Translational lung cancer research, 9(4), 1093-1100. https://doi.org/10.21037/tlcr-19-413
- Hurkmans, D. P., Tamminga, M., van Es, B., Peters, T., Karman, W., van Wijck, R. T. A., van der Spek, P. J., Tauber, T., Los, M., van Schetsen, A., Vu, T., Hiltermann, T. J. N., Schuuring, E., Aerts, J. G. J. V., Chen, S., & Groen, H. J. M. (2020). Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes. Lung Cancer, 146, 341-349. https://doi.org/10.1016/j.lungcan.2020.06.008
- Weber, S., Spiegl, B., Perakis, S. O., Ulz, C. M., Abuja, P. M., Kashofer, K., Leest, P. V. D., Azpurua, M. A., Tamminga, M., Brudzewsky, D., Rothwell, D. G., Mohan, S., Sartori, A., Lampignano, R., Konigshofer, Y., Sprenger-Haussels, M., Wikman, H., Bergheim, I. R., Kloten, V., ... Heitzer, E. (2020). Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling. Cancers, 12(6), 1-16. [1588]. https://doi.org/10.3390/cancers12061588
- Leest, P. V. D., Boonstra, P. A., Elst, A. T., Kempen, L. C. V., Tibbesma, M., Koopmans, J., Miedema, A., Tamminga, M., Groen, H. J. M., Reyners, A. K. L., & Schuuring, E. (2020). Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients. Cancers, 12(5), [1222]. https://doi.org/10.3390/cancers12051222
- Tamminga, M., Andree, K. C., Hiltermann, T. J. N., Jayat, M., Schuuring, E., van den Bos, H., Spierings, D. C. J., Lansdorp, P. M., Timens, W., Terstappen, L. W. M. M., & Groen, H. J. M. (2020). Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET. Cancers, 12(4), [896]. https://doi.org/10.3390/cancers12040896
- Tamminga, M., de Wit, S., Van De Wauwer, C., van den Bos, H., Swennenhuis, J. F., Klinkenberg, T. J., Hiltermann, T. J. N., Andree, K. C., Spierings, D. C. J., Lansdorp, P. M., van den Berg, A., Timens, W., Terstappen, L. W., & Groen, H. J. (2020). Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer: are they what they appear to be? Clinical Cancer Research, 26(7), 1656-1666. https://doi.org/10.1158/1078-0432.CCR-19-2541
- Tamminga, M. (2020). Circulating tumor cells and the micro-environment in non-small cell lung cancer. University of Groningen. https://doi.org/10.33612/diss.132713141
- 2019
- Tamminga, M., de Wit, S., Schuuring, E., Timens, W., Terstappen, L. W. M. M., Hiltermann, T. J. N., & Groen, H. J. M. (2019). Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy. Translational lung cancer research, 8(6), 854-+. https://doi.org/10.21037/tlcr.2019.11.06
- Tamminga, M., de Wit, S., Hiltermann, T. J. N., Timens, W., Schuuring, E., Terstappen, L. W. M. M., & Groen, H. J. M. (2019). Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Journal for immunotherapy of cancer, 7(1), [173]. https://doi.org/10.1186/s40425-019-0649-2
- de Wit, S., Rossi, E., Weber, S., Tamminga, M., Manicone, M., Swennenhuis, J. F., Groothuis-Oudshoorn, C. G. M., Vidotto, R., Facchinetti, A., Zeune, L. L., Schuuring, E., Zamarchi, R., Hiltermann, T. J. N., Speicher, M. R., Heitzer, E., Terstappen, L. W. M. M., & Groen, H. J. M. (2019). Single tube liquid biopsy for advanced non-small cell lung cancer. International Journal of Cancer, 144(12), 3127-3137. https://doi.org/10.1002/ijc.32056
- Pantel, K., Terstappen, L. W. M. M., manaresi, N., Groen, H. J. M., Tamminga, M., Schuuring, E., Heitzer, E., Speicher, M. R., Naume, B., kyte, J. A., & Schlange, T. (2019). Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID. Poster session presented at AACR annual meeting 2019, Atlanta, United States.
- 2018
- Tamminga, M., de Wit, S., Swennenhuis, J. F., Hiltermann, T. J. N., Schuuring, E. M., Terstappen, L. W. M., & Groen, H. J. (2018). Circulating tumor cells and tumor-derived extracellular vesicles as a possible marker for tumor response and survival in patients with non-small cell lung cancer treated with immunotherapy. Cancer Research, 78(13). https://doi.org/10.1158/1538-7445.AM2018-3606
- Andree, K. C., Tamminga, M., Mentink, A., Hilterman, T. J., Groen, H. J., & Terstappen, L. W. (2018). Circulating tumor cells in the peripheral blood and leukapheresis product of non-small cell lung cancer patients. Cancer Research, 78(13). https://doi.org/10.1158/1538-7445.AM2018-5584
- Tamminga, M., de Wit, S., Swennenhuis, J. F., Heitzer, E., Speicher, M., Hiltermann, T. J. N., Schuuring, E. M., Terstappen, L. W. M., & Groen, H. J. (2018). Circulating tumor cells measured in the pulmonary vein and radial artery during surgery of non-small cell lung cancer. Cancer Research, 78(13). https://doi.org/10.1158/1538-7445.AM2018-5594
- Tamminga, M., de Wit, S., Hilterman, J., Schuuring, E., Terstappen, L., & Groen, H. (2018). Circulating tumor cells correlate to response of immune modulating therapy in non-small cell lung cancer patients. Clinical & experimental metastasis, 35(3), 196-196.
- Andree, K., Tamminga, M., Mentink, A., Groen, H., Terstappen, L., & Hiltermann, J. (2018). Circulating tumor cells in the peripheral blood and leukapheresis product of non-small cell lung cancer patients. Clinical & experimental metastasis, 35(3), 202-203.
- 2017
- Lauri, C., Tamminga, M., Glaudemans, A. W. J. M., Juárez Orozco, L. E., Erba, P. A., Jutte, P. C., Lipsky, B. A., IJzerman, M. J., Signore, A., & Slart, R. H. J. A. (2017). Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET. Diabetes Care, 40(8), 1111-1120. https://doi.org/10.2337/dc17-0532
- Tamminga, M., de Wit, S., Swennenhuis, J. F., van de Wauwer, C., Klinkenberg, T. J., Hiltermann, T. J., Groen, H. J., & Terstappen, L. W. M. (2017). Circulating tumor cells measured in the pulmonary vein and the radial artery during surgery of non-small cell lung cancer. Cancer Research, 77(13). https://doi.org/10.1158/1538-7445.AM2017-3783
- de Wit, S., Tamminga, M., Swennenhuis, J. F., Zeune, L. L., Heitzer, E., Speicher, M., Hiltermann, T. J. N., Terstappen, L. W. M. M., & Groen, H. J. M. (2017). Liquid biopsy in NSCLC: EpCAM plus and EpCAM-circulating tumor cells, tumor derived extracellular vesicles and cell-free circulating tumor DNA. Cancer Research, 77. https://doi.org/10.1158/1538-7445.AM2017-LB-250
- 2016
- Tamminga, M., Groen, H. H. J. M., & Hiltermann, T. J. N. (2016). Investigating CTCs in NSCLC-a reaction to the study of Jia-Wei Wan: a preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer. Journal of thoracic disease, 8(6), 1032-6. https://doi.org/10.21037/jtd.2016.04.17
ID: 15656079